US2016213795A1PendingUtilityA1
Egcg stabilized gold nanoparticles, therapies and sensing
Est. expiryNov 17, 2024(expired)· nominal 20-yr term from priority
Inventors:Kattesh V. KattiRaghuraman KannanKavita K. KattiSatish K. NuneCathy S. CutlerCharles CaldwellRavi ShuklaNripen ChandaAjit ZambreAnandhi Upendran
A61K 41/00A61P 35/00A61K 51/1251A61K 51/1244A61K 31/353A61K 9/148A61K 33/242
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides stabilized, biocompatible gold nanoparticles that are stabilized with material from epigallocatechin Gallate (EGCg), which is a polyphenols- or flavanoids-rich plant material that can be obtained from green tea. The EGCg is an antioxidant reducing agent derived from green tea. The gold nanoparticles of the invention can be radioactive or non radioactive and are formed via a simple room temperature fabrication method. Therapy and sensing methods are conducted with nanoparticles of the invention.
Claims
exact text as granted — not AI-modified1 . Gold nanoparticles stabilized with a material coating of epigallocatechin Gallate (EGCg).
2 . The gold nanoparticles of claim 1 , wherein the gold nanoparticles comprise EGCG 198 AuNP.
3 . The gold nanoparticles of claim 1 , consisting of EGCG 198 AuNP.
4 . A medical therapeutic formulation comprising the gold nanoparticles of claim 3 .
5 . A method of therapy comprising introducing stabilized gold nanoparticles of claim 3 into a human or animal subject and conducting gold nanoparticle enhanced therapy.
6 . The gold nanoparticles of claim 3 , in an aqueous solution having a physiological pH.
7 . A method of sensing comprising introducing stabilized gold nanoparticles of claim 3 into a human or animal subject and conducting gold nanoparticle enhanced imaging.
8 . A method of therapy comprising introducing stabilized gold nanoparticles of claim 2 into a human or animal subject and conducting gold nanoparticle enhanced therapy.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.